Oct 13, 2022
VINCOV-19, an antidote, and a cure against COVID-19 completes Phase 2 clinical trials
Posted by Quinn Sena in category: biotech/medical
VINS Bioproducts Limited, Hyderabad in collaboration with the Centre for Cellular and Molecular Biology (CCMB) and the University of Hyderabad (UoH), announced the successful completion of Phase 2 clinical trials of VINCOV-19, India’s first antidote and cure against SARS-CoV-2 virus.
VINCOV-19 is now ready for market authorisation and for simultaneous Phase 3 clinical trials.